Procavea Biotech

Startup

Procavea Biotech is a recently incorporated ETH Zurich Spin-off that brings a unique protein-based delivery platform to the siRNA market. While RNA-based therapeutics have transformative potential in medicine, the limited delivery technologies available to turn these molecules into effective drugs hold back their true power. Procavea Biotech has developed an innovative solution to this problem: a novel RNA delivery platform based on nonviral protein cages. Although a handful of RNA-based therapies have been approved, delivering these molecules to organs other than the liver still poses a significant challenge. At Procavea, our goal is to leverage the engineerability of our delivery system and the programmability of genetic medicines to address currently intractable disease targets with novel RNA-based drugs.

website